Download PDF
Horm Metab Res 2015; 47(09): 643-651
DOI: 10.1055/s-0035-1554689
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis

J. Chen   *
1   Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
,
Q.-Y. Zhou   *
1   Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
,
J.-D. Wang
1   Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
› Author Affiliations
Further Information

Publication History

received 15 February 2015

accepted 19 May 2015

Publication Date:
02 July 2015 (online)

Also available at
    Permissions and Reprints

Abstract

We conducted a meta-analysis of randomized and 2-arm prospective or retrospective studies that compared the efficacy of PTX and TPTX+AT in patients with medically uncontrollable secondary HPT due to chronic renal failure. Citations were identified in the Medline, Cochrane, EMBASE, and Google Scholar databases through April 2014. The primary outcome of interest was HPT recurrence rate, while secondary outcomes included changes in serum calcium (Ca++ ), parathyroid hormone (PTH), alkaline phosphatase (ALP), and phosphate (P) levels. Five studies were included in the present analysis. The NOS score of all the included studies was 7 or above, and heterogeneity among the studies was minimal for 3 of the 5 outcomes. The HPT recurrence rate was similar for patients who underwent SPTX vs. TPTX+AT [odds ratio (OR)=0.825; 95% confidence interval (CI)=0.368 to 1.846; p=0.639]. The changes in serum Ca++ , PTH, ALP, and P were also similar between the 2 treatment groups (Ca++ : Std diff in means=− 0.166; 95% CI=− 0.703 to 0.371; p=0.545; PTH: pooled diff in means=561.17; 95% CI=–174.30 to 1296.6; p=0.135; ALP: pooled diff in means=0.58; 95% CI=− 70.07 to 71.24; p=0.987; P: pooled Std diff in means=0.26; 95% CI=− 0.091 to 0.630; p=0.143). Our findings indicate that SPTX and TPTX+AT are equally successful in preventing recurrent HPT and improving secondary HPT. We therefore, conclude that the choice of procedure can be left to the surgeons.

Key words

surgical treatment - hyperparathyroidism - chronic renal failure - parathyroidectomy - chronic kidney disease

* The first 2 authors contributed equally to this work


 

  • References

  • 1 Douthat WG, Castellano M, Berenguer L, Guzmán MA, de Arteaga J, Chiurchiu CR, Massari PU, Garay G, Capra R, de La Fuente JL. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina. Nefrologia 2013; 33: 657-666
    PubMedGoogle Scholar
  • 2 Fernandez-Martin JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant 2013; 28: 1922-1935
    CrossrefPubMedGoogle Scholar
  • 3 Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44 (Suppl. 02) 34-38
    CrossrefPubMedGoogle Scholar
  • 4 Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187
    CrossrefPubMedGoogle Scholar
  • 5 Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417-E423
    CrossrefPubMedGoogle Scholar
  • 6 Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
    CrossrefPubMedGoogle Scholar
  • 7 Cueto-Manzano AM, Cortes-Sanabria L, Martinez-Ramirez HR, Rojas-Campos E, Gomez-Navarro B, Castillero-Manzano M. Prevalence of chronic kidney disease in an adult population. Arch Med Res 2014; 45: 507-513
    CrossrefPubMedGoogle Scholar
  • 8 Lee SW, Kim YC, Oh SW, Koo HS, Na KY, Chae DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011; 26: 3975-3980
    CrossrefPubMedGoogle Scholar
  • 9 Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822
    CrossrefPubMedGoogle Scholar
  • 10 Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118: c269-c277
    CrossrefPubMedGoogle Scholar
  • 11 Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 2011; 6: 913-921
    CrossrefPubMedGoogle Scholar
  • 12 Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 2007; 13: 397-411
    PubMedGoogle Scholar
  • 13 Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing AJ. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991; 6 (Suppl. 01) 5-35
    CrossrefPubMedGoogle Scholar
  • 14 Shih ML, Duh QY, Hsieh CB, Lin SH, Wu HS, Chu PL, Chen TY, Yu JC. Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 2009; 33: 248-254
    CrossrefPubMedGoogle Scholar
  • 15 Yano S, Sugimoto T, Tsukamoto T, Yamaguchi T, Hattori T, Sekita KI, Kaji H, Hattori S, Kobayashi A, Chihara K. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Horm Metab Res 2003; 35: 259-264
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Hubbard JGH, Sebag F, Maweja S, Henry JF. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 2006; 141: 235-239
    CrossrefPubMedGoogle Scholar
  • 17 Committee K . KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130
    PubMedGoogle Scholar
  • 18 Steddon S, Sharples E. Clinical Practice Guideline CKD-Mineral and Bone Disorders (CKD-MBD). UK Renal Association 2010;
    PubMedGoogle Scholar
  • 19 Alveryd A. Parathyroid glands in thyroid surgery. I. Anatomy of parathyroid glands. II. Postoperative hypoparathyroidism-identification and autotransplantation of parathyroid glands. Acta Chir Scand 1968; 389: 1-120
    PubMedGoogle Scholar
  • 20 Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960; 1: 793-799
    PubMedGoogle Scholar
  • 21 Wells SA, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM. Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 1975; 78: 34-44
    PubMedGoogle Scholar
  • 22 Wells GSB, O'Connell D, Peterson J, Welch V, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. The 3rd Symposium on Systematic Reviews: Beyond the Basics. Oxford; England: 2000
    Google Scholar
  • 23 Charhon SA, Berland YF, Olmer MJ, Delawari E, Traeger J, Meunier PJ. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 1985; 27: 426-435
    CrossrefPubMedGoogle Scholar
  • 24 Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Medicine 1997; 127: 820-826
    PubMedGoogle Scholar
  • 25 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002; 21: 1539-1558
    CrossrefPubMedGoogle Scholar
  • 26 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
    CrossrefPubMedGoogle Scholar
  • 27 Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320: 1574-1577
    CrossrefPubMedGoogle Scholar
  • 28 Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drueke TB. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992; 3: 1008-1017
    PubMedGoogle Scholar
  • 29 Nichols P, Owen JP, Ellis HA, Farndon JR, Kelly PJ, Ward MK. Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med 1990; 77: 1175-1193
    CrossrefPubMedGoogle Scholar
  • 30 Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 2012; 36: 318-326
    CrossrefPubMedGoogle Scholar
  • 31 Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991; 15: 745-750
    CrossrefPubMedGoogle Scholar
  • 32 Kuo LE, Wachtel H, Karakousis G, Fraker D, Kelz R. Parathyroidectomy in dialysis patients. J Surg Res 2014; 190: 554-558
    CrossrefPubMedGoogle Scholar
  • 33 Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?. Surgery 2006; 139: 174-180
    CrossrefPubMedGoogle Scholar
  • 34 Schneider R, Bartsch DK, Schlosser K. Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg 2013; 37: 2155-2161
    CrossrefPubMedGoogle Scholar
  • 35 Schneider R, Waldmann J, Ramaswamy A, Fernandez ED, Bartsch DK, Schlosser K. Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 2011; 35: 1260-1265
    CrossrefPubMedGoogle Scholar
  • 36 Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E, Mullineris B, Dei Poli M. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001; 233: 65-69
    CrossrefPubMedGoogle Scholar
  • 37 Tanaka Y, Seo H, Tominaga Y, Funahashi H, Matsui N, Takagi H. Factors related to the recurrent hyperfunction of autografts after total parathyroidectomy in patients with severe secondary hyperparathyroidism. Surg Today 1993; 23: 220-227
    CrossrefPubMedGoogle Scholar
  • 38 Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 1992; 16: 595-602 discussion 602–593
    CrossrefPubMedGoogle Scholar
  • 39 Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; 20: 744-750
    CrossrefPubMedGoogle Scholar
  • 40 Neyer U, Hoerandner H, Haid A, Zimmermann G, Niederle B. Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 2002; 17: 625-629
    CrossrefPubMedGoogle Scholar
  • 41 Niederle B, Horandner H, Roka R, Woloszczuk W. Morphologic and functional studies to prevent graft-dependent recurrence in renal osteodystrophy. Surgery 1989; 106: 1043-1048
    PubMedGoogle Scholar
  • 42 Kuo LE, Wachtel H, Fraker D, Kelz R. Reoperative parathyroidectomy: who is at risk and what is the risk?. J Surg Res 2014; 191: 256-261
    CrossrefPubMedGoogle Scholar
  • 43 Low T-HH, Clark J, Gao K, Eris J, Shannon K, O’Brien C. Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism. ANZ J Surg 2009; 79: 378-382
    CrossrefPubMedGoogle Scholar